should i take a glp 1 for weight loss GLP-1 Specialist in Langhorne and Philadelphia, PA Oral GLP-1 for Medical Weight

Weight regain after discontinuation Within a year of stopping GLP-1 therapy, 49% of patients were heavier than when they started (Abdel-Bary et al

The incidence is approximately 0.4% at doses up to 450mg daily, which sounds small until you realize that certain conditions dramatically increase this baseline risk

[DOI] [PMC free article] [PubMed] [Google Scholar] 21.Liutkus J, Rosas Guzman J, Norwood P, et al

Animal studies have raised concerns that medicines like Ozempic and Mounjaro may cause thyroid tumors, including cancer

the company's guarantee terms reference tirzepatide as one example of prescribed medication, depending on eligibility and availability As a dual GIP/GLP-1 receptor agonist, it works on two hormone pathways Some clinical research suggests tirzepatide may produce slightly more weight loss than semaglutide on average in study populations, though individual responses vary significantly* Higher price point reflects dual-action mechanism These studies evaluated FDA-approved branded medications under controlled conditions, not compounded formulations

Having a clearly defined protocol with predetermined switching criteria, discussed in advance with your healthcare provider, reduces the emotional burden of making switch decisions in the moment